#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Sujal Shah Email
President and CEO . CymaBay Therapeutics
How to contact Sujal Shah
Join and see Sujal's contact info for free!Phone
Current Roles
Employees:
122Revenue:
$6.8MAbout
CymaBay Therapeutics, Inc. (CBAY) is a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet medical need. Seladelpar is a potent, selective, orally active PPAR agonist, currently in development for the treatment of patients with primary biliary cholangitis (PBC), an autoimmune liver disease, and with non-alcoholic steatohepatitis (NASH). For additional information about CymaBay visit www.cymabay.com.CymaBay Therapeutics Address
7575 Gateway BlvdNewark, CA
United States